Article info
PDFOriginal Article
Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis
- Correspondence to: Ina Kötter, MD, Department of Internal Medicine II, (Hematology/Oncology/Immunology/Rheumatology) University Hospital, Otfried-Müller Strasse 10, D-72076 Tübingen, Germany; ina.koetter{at}med.uni-tuebingen.de
Citation
Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis
Publication history
- Accepted October 14, 2002
- First published April 1, 2003.
Online issue publication
March 22, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2003 British Journal of Ophthalmology